Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 6, 2021 (5 years ago)

Tetracaine HCl Nasal Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Tetracaine HCl Nasal Solution, 4%, 240 mL per bottle, Multiple Dose Container for Intranasal Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-1195-03, packaged in bottles.

Affected NDC 5446-1195-03

Compare with the code on your package — it is the most precise check available.

Drug: Tetracaine

Recalling firm
Edge Pharma, LLC
NDC code
05446-1195-03
Origin
VT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0447-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tetracaine recalls

See all
Class III · Low risk

LET Gel

Product Mix-up: Incorrect Product Formulation

Terminated Labeling / mix-up Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop NDC 73271-1003-1 D-0140-2024
Class II · Moderate risk

TETRACAINE 1% Tetracaine HCI Injection

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Vitae Enim Vitae Scientific, Inc. NDC 42494-437-10 D-0741-2022

Other recalls by Edge Pharma, LLC

All 2021 recalls